S Sassano‐Higgins, D Baron, G Juarez… - Depression and …, 2016 - Wiley Online Library
Ketamine was discovered in the 1960s and released for public use in 1970. Originally developed as a safer alternative to phencyclidine, ketamine is primarily used in clinical …
R Shahani, C Streutker, B Dickson, RJ Stewart - Urology, 2007 - Elsevier
OBJECTIVES: Ketamine hydrochloride is an N-methyl-d-aspartic acid receptor antagonist used as an anesthetic agent in human and veterinary procedures. Increasingly, it is being …
G Bokor, PD Anderson - Journal of pharmacy practice, 2014 - journals.sagepub.com
Ketamine is a dissociative anesthetic and substance of abuse. Numerous effects can result from the abuse of ketamine. Death from acute direct toxicity is rare. Ketamine can alter …
R Machado-Vieira, G Salvadore… - Pharmacology & …, 2009 - Elsevier
Existing treatments for major depressive disorder (MDD) usually take weeks to months to achieve their antidepressant effects, and a significant number of patients do not have …
Abstract Study Type-Symptom prevalence (prospective cohort) Level of Evidence 1b What's known on the subject? and What does the study add? Case series have described lower …
LJ Schep, RJ Slaughter, M Watts, E Mackenzie… - Clinical …, 2023 - Taylor & Francis
Introduction Ketamine is a pharmaceutical drug possessing both analgesic and anaesthetic properties. As an anaesthetic, it induces anaesthesia by producing analgesia with a state of …
C Martial, H Cassol, V Charland-Verville… - Consciousness and …, 2019 - Elsevier
The real or perceived proximity to death often results in a non-ordinary state of consciousness characterized by phenomenological features such as the perception of …
L Wang, JE Min, E Krebs, E Evans, D Huang… - International Journal of …, 2017 - Elsevier
Background Polydrug use may challenge effective treatment for substance use disorders. We evaluate whether secondary substance use modifies the association between treatment …
In 2016 the Psychoactive Substances Bill banned trading but not possession of all current and future novel psychoactive substances (NPS), sometimes incorrectly called “legal highs,” …